Press Release 鈥  8/8/2017

龙8娱乐app下载报道Dow Agrosciences And Arcadia Biosciences Developing, Commercializing Improved Wheat Quality Trait_龙8娱乐app下载官网资讯

Combined Expertise to Accelerate Development and Commercialization of New Crop Trait Focused on Improved Nutrition

DAVIS, Calif. and INDIANAPOLIS (August 8, 2017) 鈥 Arcadia Biosciences, Inc. (Nasdaq: RKDA) and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announced a collaboration to jointly develop and commercialize a breakthrough improved wheat quality trait in North America. The collaboration leverages Arcadia鈥檚 leading non-GM TILLING trait development platform with Dow AgroSciences鈥 enabling technology platforms, high-quality elite germplasm and global commercial channels.

Under the collaboration, the companies will further develop and commercialize an improved wheat quality trait, which has completed initial field trials and is advancing to next-stage field trials. Dow AgroSciences will introgress Arcadia鈥檚 trait into its proprietary elite germplasm lines and manage all aspects related to the trait commercialization. Certain development costs will be co-funded under the collaboration agreement, and the commercial value will be shared by Arcadia and Dow AgroSciences.聽

鈥淲heat is a staple crop around the globe, and our scientific expertise can help improve the nutritional profile and quality of this important crop by enhancing its value for human health and consumption while also enabling farmers to produce an added value crop,鈥 said Rolando Alegria, global business leader, wheat, forages and sorghum, Dow AgroSciences.聽

鈥淭his collaboration reflects the unique nature of Arcadia鈥檚 business model, expanding our access into the growing market of improved nutrition traits with an established leader in agriculture,鈥 said Raj Ketkar, president and CEO of Arcadia Biosciences. 鈥淒ow AgroSciences鈥 experience in value-added crops is a perfect complement to Arcadia鈥檚 portfolio of nutritional quality traits. Together, we can accelerate the development and commercial deployment of improved nutrition crop traits to deliver significant added value to growers, food manufacturers and consumers.鈥澛

Specific financial and trait details of the collaboration were not disclosed.

About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops agricultural products that create added value for farmers while benefitting the environment and enhancing human health. Arcadia鈥檚 agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia鈥檚 nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. For more information, visit聽www.arcadiabio.com.

About Dow AgroSciences聽
Dow AgroSciences discovers, develops, and brings to market crop protection and plant biotechnology solutions for the growing world. Based in Indianapolis, Indiana, USA, Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $6.2 billion in 2016. Learn more at聽www.dowagro.com. Follow Dow AgroSciences on聽Facebook,聽Twitter,聽LinkedIn, and聽Google+, or subscribe to our聽News Release RSS Feed.

Media Contacts

Arcadia Biosciences
Jeff Bergau
jeffbergau@arcadiabio.com
312-217-0419

Dow AgroSciences
Kenda Resler Friend
kresler@dow.com
317-337-4743

庐鈩rademark of The Dow Chemical Company (鈥淒ow鈥) or an affiliated company of Dow.

Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to Arcadia鈥檚 strategic partnership with Dow AgroSciences to develop and commercialize agricultural traits. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: Arcadia鈥檚 and its partners鈥 and affiliates鈥 ability to develop commercial products incorporating its traits, including healthy grain traits, and complete the regulatory review process for such products; Arcadia鈥檚 compliance with laws and regulations that impact the company鈥檚 business, and changes to such laws and regulations; Arcadia鈥檚 future capital requirements and ability to satisfy its capital needs; and the other risks set forth in Arcadia鈥檚 filings with the Securities and Exchange Commission from time to time, including the risks set forth in Arcadia鈥檚 annual report on Form 10K for the year ended December 31, 2016 and other filings. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.

{ad.bottom} 条评论